Alterity Therapeutics Limited (PRNAF)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.0109 (-78.42%)
At close: Jun 16, 2025
Alterity Therapeutics Employees
Alterity Therapeutics had 9 employees as of June 30, 2025. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
$396,200
Profits / Employee
-$884,914
Market Cap
79.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 9 | -1 | -10.00% |
| Jun 30, 2024 | 10 | -1 | -9.09% |
| Jun 30, 2023 | 11 | -1 | -8.33% |
| Jun 30, 2022 | 12 | 1 | 9.09% |
| Jun 30, 2021 | 11 | -1 | -8.33% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Alterity Therapeutics News
- 3 days ago - Alterity Therapeutics (ATHE) Reports Promising Phase 2 Trial Results for ATH434 - GuruFocus
- 10 days ago - Alterity Therapeutics (ATHE) Secures A$20M in New Funding - GuruFocus
- 10 days ago - Alterity Therapeutics raises A$20 million in strategic placement - Seeking Alpha
- 10 days ago - Alterity Therapeutics Raises A$20.0 million in Strategic Placement - GlobeNewsWire
- 16 days ago - Alterity Therapeutics to Present at the Biotech Showcase - GlobeNewsWire
- 7 weeks ago - Appendix 4C – Q4 FY25 Quarterly Cash Flow Report - GlobeNewsWire
- 7 weeks ago - Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy - GlobeNewsWire
- 2 months ago - Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study - GlobeNewsWire